Global X Management Company’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$49K Sell
1,913
-160
-8% -$3.73K ﹤0.01% 1101
2018
Q1
$42K Buy
2,073
+521
+34% +$12.2K ﹤0.01% 1043
2017
Q4
$31K Buy
1,552
+352
+29% +$6.92K ﹤0.01% 994
2017
Q3
$25K Buy
1,200
+173
+17% +$2.92K ﹤0.01% 1032
2017
Q2
$15K Buy
1,027
+875
+576% +$14.6K ﹤0.01% 1190
2017
Q1
$2K Hold
152
﹤0.01% 1200
2016
Q4
$2K Hold
152
﹤0.01% 1089
2016
Q3
$4K Hold
152
﹤0.01% 1080
2016
Q2
$5K Buy
+152
New +$4.78K ﹤0.01% 938

Other funds holding DPLO

Global X Management Company's DPLO Position: Q2 2018 in Review

Global X Management Company reduced its DIPLOMAT PHARMACY, INC. (DPLO) stake by 7.7% in Q2 2018, selling an estimated $3.73K and leaving 1,913 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Global X Management Company first reported a position in DPLO in Q2 2016 and has held it in 9 quarters since. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Global X Management Company held 1,913 shares of DIPLOMAT PHARMACY, INC. worth $49K as of Q2 2018.
  • Global X Management Company sold 160 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $3.73K.
  • DIPLOMAT PHARMACY, INC. made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1101 holding.
  • Global X Management Company first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and has held it in 9 quarters since.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.